Vistagen Therapeutics (VTGN) Return on Equity [ROE] (2017 - 2026)
Vistagen Therapeutics (VTGN) recorded Return on Equity [ROE] of -225.47% in fiscal Q1 2027 (quarter ended Jun 30, 2026), down 137.73 percentage points from -87.74% a year earlier and down 64.19 percentage points from the prior quarter.
Powered by 
Analysis
Vistagen Therapeutics (VTGN) Return on Equity [ROE] (2017 - 2026) Analysis & Trends
For FY2026 (ended Mar 31, 2026), Vistagen Therapeutics reported Return on Equity [ROE] of -131.63%, down 75.95 percentage points from FY2025.
- Annual Return on Equity [ROE] has a five-year change of -90.05 percentage points (FY2021 to FY2026).
- Across earlier fiscal years, Return on Equity [ROE] came in at -55.68% in FY2025 (-9.21 pp), -46.47% in FY2024 (+107.83 pp), -154.30% in FY2023 (-93.34 pp) and -60.96% in FY2022 (-19.38 pp).
- The fiscal Q1 2027 figure is the lowest quarterly Return on Equity [ROE] since fiscal Q1 2024.
- On a year-over-year basis, Return on Equity [ROE] has declined for seven consecutive quarters, with an average year-over-year change of -42.48 percentage points over the last eight quarters.
- Peak year-over-year performance for Return on Equity [ROE] in the last five years was a gain of 459.68 percentage points in fiscal Q1 2025, against a drop of 382.02 percentage points in fiscal Q1 2024 at the low end.
- Per Business Quant, the preceding three fiscal quarters came in at -161.28% (Q4 2026), -114.36% (Q3 2026) and -101.11% (Q2 2026).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROE (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | 82.09% |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 25.32% |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | - |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | 7.21% |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | 84.40% |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | 21.39% |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | 83.75% |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | -18.38% |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | 4.97% |
| 10 | Vistagen Therapeutics | 12.43 Mn | 12.43 Mn | - | -225.47% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -225.47% |
| Mar 31, 2026 | -161.28% |
| Dec 31, 2025 | -114.36% |
| Sep 30, 2025 | -101.11% |
| Jun 30, 2025 | -87.74% |
| Mar 31, 2025 | -67.87% |
| Dec 31, 2024 | -54.34% |
| Sep 30, 2024 | -40.01% |
| Jun 30, 2024 | -30.30% |
| Mar 31, 2024 | -24.72% |
| Dec 31, 2023 | -40.35% |
| Sep 30, 2023 | -166.98% |
| Jun 30, 2023 | -489.98% |
| Mar 31, 2023 | -361.77% |
| Dec 31, 2022 | -253.42% |
| Sep 30, 2022 | -170.46% |
| Jun 30, 2022 | -107.96% |
| Mar 31, 2022 | -66.02% |
| Dec 31, 2021 | -46.42% |
| Sep 30, 2021 | -38.55% |
API Access
Vistagen Therapeutics Return on Equity [ROE] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=VTGN&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-equity-[roe]", "ticker": "VTGN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=VTGN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();